Cingulate Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cingulate Inc. on July 28, 2023. The filing addresses two separate notices received from the Nasdaq Stock Market LLC regarding the Company's failure to meet continued listing requirements for its common stock (CING) and warrants (CINGW).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, or debt. The report focuses exclusively on regulatory compliance status rather than operational financial performance.
Material Changes and Listing Status
- Stockholders' Equity Deficiency: The Company received a notice on May 19, 2023, regarding non-compliance with the minimum stockholders' equity requirement (Rule 5550(b)(1)). On July 28, 2023, Nasdaq granted an extension until November 13, 2023, to regain compliance. This extension is conditioned on achieving milestones, including a plan to raise additional capital.
- Minimum Bid Price Deficiency: On July 28, 2023, the Company received notice of non-compliance with the $1.00 minimum bid price requirement (Rule 5550(a)(2)) based on the closing bid price over the last 30 consecutive business days.
Outlook, Risks, and Contingencies
Compliance Deadlines:
- Equity Requirement: The Company must evidence compliance by November 13, 2023, upon filing its periodic report for the quarter ending September 30, 2023. Failure to do so may result in delisting.
- Bid Price Requirement: The Company has 180 calendar days (until January 24, 2024) to regain compliance. Compliance is achieved if the bid price closes at or above $1.00 for 10 consecutive business days.
Remediation Options: The Company is considering options to regain compliance, including raising additional capital and potentially effecting a reverse stock split. Management notes that a reverse stock split could negatively affect the stock price.
Risks of Delisting: If the Company fails to regain compliance, its securities may be delisted. Consequences include reduced liquidity, potential material decline in stock price, loss of market efficiencies, and impaired ability to raise capital. The Company retains the right to appeal any delisting determination to a Nasdaq hearings panel.
Investor Verification Checklist
- Verify the Company's progress in raising additional capital to meet the stockholders' equity milestone by November 13, 2023.
- Monitor the daily closing bid price of CING to determine if it sustains $1.00 or higher for 10 consecutive business days before January 24, 2024.
- Review upcoming periodic reports (10-Q for Q3 2023) for evidence of regained equity compliance.
- Watch for announcements regarding a potential reverse stock split and its impact on share count and price.